Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.
Brain computer interface (BCI) company Neuralink has been given regulatory approval to start a new trial of its implant to see if it can be used to control a robotic arm. If it proves to be ...
We preselected all newsletters you had before unsubscribing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results